Posts

Showing posts from December, 2021

How COVID-19 Changed The MedTech In GCC Countries

Image
The first peak of COVID-19 was documented on July 19, 2020, where around 14.3 million people were affected by the pandemic worldwide. The GCC region saw a total of 0.57 million reported COVID-19 cases on that very same day.  To mitigate any further spreading of COVID-19 in the GCC nations, the governments initiated the promotion of the MedTech industry in the form of in-vitro diagnostic kits, smart AI medical devices, ventilators, and surgical masks, among others. Additionally, smart robots were launched to curb COVID-19. The UAE set up virtual hospitals while Saudi Arabia launched GHAD (a Unified Electronic Platform). These and many other drastic measures brought the pandemic in the GCC nations under control. The total number of COVID-19 cases in the GCC nations fell from 4.03% to 1.05% of the global COVID-19 cases by October 11, 2021.  As of now, government bodies and regulators in the GCC nations have taken additional steps to improve the MedTech industry. These include i...

Central Nervous System Lymphoma Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

Central Nervous System Lymphoma , is a rare type of non-Hodgkin lymphoma (NHL) in which malignant cells from lymph tissue form in the brain or spinal cord or spread from other parts of the body to the brain or spinal cord. When it is formed in the brain it is known as primary CNS lymphoma (PCNSL) and when it spreads from other parts of the body to the brain or spinal cord it is known as Secondary CNS lymphoma. Because the eye is so close to the brain, primary CNS lymphoma can also start in the eye. Both primary and secondary CNS lymphomas are rare diseases. DelveInsight's  Central Nervous System Lymphoma Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Central Nervous System Lymphoma, historical and forecasted epidemiology as well as the Central Nervous System Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some key facts of Central Nervous System Lymphoma ...

Central Nervous System Lymphoma Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

Central Nervous System Lymphoma , is a rare type of non-Hodgkin lymphoma (NHL) in which malignant cells from lymph tissue form in the brain or spinal cord or spread from other parts of the body to the brain or spinal cord. When it is formed in the brain it is known as primary CNS lymphoma (PCNSL) and when it spreads from other parts of the body to the brain or spinal cord it is known as Secondary CNS lymphoma. Because the eye is so close to the brain, primary CNS lymphoma can also start in the eye. Both primary and secondary CNS lymphomas are rare diseases. DelveInsight's  Central Nervous System Lymphoma Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Central Nervous System Lymphoma, historical and forecasted epidemiology as well as the Central Nervous System Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some key facts of Central Nervous System Lymphoma ...

Ovarian Cancer Market, Pipeline, Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

DelveInsight's " Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030 " report delivers an in-depth understanding of the Ovarian Cancer, historical and forecasted epidemiology as well as the Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Ovarian cancer is a disease that affects women and is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60. Request for free Sample Report: https://www.delveinsight.com/sample-request/ovarian-cancer-market View Report: https://www.delveinsight.com/report-store/ovarian-cancer-market Some key ...

ABSSSI Market Size, Epidemiology, Treatment, Therapies and Companies by DelveInsight| Paratek Pharmaceutical, Melinta, Durata Therapeutics, Cubist Pharmaceutical, The Medicine Company and Others

DelveInsight's 'Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market Insights, Epidemiology and Market Forecast-2030' report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Acute Bacterial Skin and Skin-Structure Infection in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. Some Facts of the ABSSSI Report : ·          As per Delveinsight’s analysis, the total 7MM Incident cases of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in 2017 were 7,259,777, out of which the highest Incident cases of this disease were seen in the United States. ·          As per DelveInsight’s estimate, there were 1,942,229 male patients and 1,406,442 female cases suffering from ABSSSI in 2017 in the United States. ·          In United States, it is ...